文献
J-GLOBAL ID:201802252142082416
整理番号:18A0236748
骨髄異形成症候群/骨髄増殖性腫瘍におけるアザシチジンとの併用におけるルクソリチニブの第II相試験【Powered by NICT】
A phase II trial of ruxolitinib in combination with azacytidine in myelodysplastic syndrome/myeloproliferative neoplasms
著者 (23件):
Assi Rita
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Kantarjian Hagop M.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Garcia-Manero Guillermo
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Cortes Jorge E.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Pemmaraju Naveen
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Wang Xuemei
(Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Nogueras-Gonzalez Graciela
(Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Jabbour Elias
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Bose Prithviraj
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Kadia Tapan
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Dinardo Courtney D.
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Patel Keyur
(Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Bueso-Ramos Carlos
(Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Zhou Lingsha
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Pierce Sherry
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Gergis Romany
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Tuttle Carla
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Borthakur Gautam
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Estrov Zeev
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Luthra Rajyalakshmi
(Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Hidalgo-Lopez Juliana
(Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Verstovsek Srdan
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
,
Daver Naval
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, Texas)
資料名:
American Journal of Hematology
(American Journal of Hematology)
巻:
93
号:
2
ページ:
277-285
発行年:
2018年
JST資料番号:
E0721B
ISSN:
0361-8609
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)